Company Performance Metrics
- Ittai Harel: InvestorPast Role: Vertos Medical, Director Board Of Directors
- Jonathan Rosenfeld: Founder & CTO
Cellular Intelligence develops AI-driven foundation models and platforms to predict and control cell behavior for regenerative medicine. The company builds a universal virtual cell-signaling model that learns how cells respond to complex signal combinations over time. Using a proprietary capsule-based system, it generates dynamic cellular data and
trains large-scale predictive models to guide cell differentiation and analyze disease mechanisms.
Cellular Intelligence applies these capabilities to design and optimize regenerative medicine protocols, predict drug responses, and model disease in silico. Its technology supports the development of cell-therapy programs and other applications that seek to engineer living tissues and cell states with greater precision.
